The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.

Close X
Other videos you might like

Recent Videos


CardioNerds @AHA23: The SELECT Trial

A Michael Lincoff , Ahmed Ghoneem,

Watch time: 11m 47s


AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall,

Watch time: 21m 35s


CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi E Ndumele,

Watch time: 14m 32s

Video Series

e-SPACE Heart Failure 2023

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 21s (18 videos)